The fight against cancer is a multi-billion dollar industry, generating over $200 billion annually for pharmaceutical companies – exceeding even the revenue from the latest obesity drugs. Yet, a sobering analysis reveals a disturbing truth: less than half of the cancer treatments available have definitively proven to extend a patient’s life, despite often inflicting significant suffering.
